Amgen wraps up Enbrel recall

Amgen's recall of 827,529 vials of Enbrel (etanercept) 25 mg, completed in January, was due to loose or missing caps from diluent syringes included in packaging with vials. The company said that the problem arose from a third party contractor and that corrective steps have been executed. Amgen expects approval of new screw caps for the syringes by summer. Of the 13 lots recalled, the firm received only 253 vials as the rest were either consumed or expired (1"The Pink Sheet" March 27, 2006, p. 29)...